Using Multigroup-Multiphase Latent State-Trait Models to Study Treatment-Induced Changes in Intra-Individual State Variability: An Application to Smokers' Affect by Christian Geiser et al.
METHODS
published: 22 July 2016
doi: 10.3389/fpsyg.2016.01043
Frontiers in Psychology | www.frontiersin.org 1 July 2016 | Volume 7 | Article 1043
Edited by:
Holmes Finch,
Ball State University, USA
Reviewed by:
Antonio Calcagnì,
Hungarian Academy of Science,
Hungary
Antonio Zuffiano,
Liverpool Hope University, UK
*Correspondence:
Christian Geiser
christian.geiser@usu.edu
Specialty section:
This article was submitted to
Quantitative Psychology and
Measurement,
a section of the journal
Frontiers in Psychology
Received: 05 May 2016
Accepted: 27 June 2016
Published: 22 July 2016
Citation:
Geiser C, Griffin D and Shiffman S
(2016) Using Multigroup-Multiphase
Latent State-Trait Models to Study
Treatment-Induced Changes in
Intra-Individual State Variability: An
Application to Smokers’ Affect.
Front. Psychol. 7:1043.
doi: 10.3389/fpsyg.2016.01043
Using Multigroup-Multiphase Latent
State-Trait Models to Study
Treatment-Induced Changes in
Intra-Individual State Variability: An
Application to Smokers’ Affect
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Sometimes, researchers are interested in whether an intervention, experimental
manipulation, or other treatment causes changes in intra-individual state variability. The
authors show how multigroup-multiphase latent state-trait (MG-MP-LST) models can be
used to examine treatment effects with regard to both mean differences and differences
in state variability. The approach is illustrated based on a randomized controlled trial
in which N = 338 smokers were randomly assigned to nicotine replacement therapy
(NRT) vs. placebo prior to quitting smoking. We found that post quitting, smokers in
both the NRT and placebo group had significantly reduced intra-individual affect state
variability with respect to the affect items calm and content relative to the pre-quitting
phase. This reduction in state variability did not differ between the NRT and placebo
groups, indicating that quitting smoking may lead to a stabilization of individuals’ affect
states regardless of whether or not individuals receive NRT.
Keywords: smokers’ affect state variability, latent state-trait models, multigroup confirmatory factor analysis,
nicotine replacement therapy, ecological momentary assessment (EMA)
In intervention, evaluation, and experimental studies, researchers are interested in testing the
effects of an intervention, program, or experimental manipulation on one or more outcome
variables (for simplicity and in order to save space, we hereafter refer to interventions, programs,
experimental manipulations, etc., simply as “treatment”). Frequently, such studies include multiple
groups (e.g., one or more treatment and control groups) that are compared in order to determine
the magnitude and statistical significance of a potential treatment effect. Classical designs are
control/treatment pretest-posttest designs in which individuals are either randomly assigned to
treatment and control groups (true experimental design) or non-randomly assigned (e.g., when
individuals self-select into groups or are members of pre-existing groups; quasi-experimental
design). The pretest allows researchers to check for pre-existing differences between groups (due
to e.g., “unhappy” randomization or a quasi-experimental design), whereas the comparison of
pretest and posttest differences between groups allows testing the significance and size of a potential
treatment effect.
In many experimental and quasi-experimental studies, researchers focus on mean differences
between (a) groups and (b) across time [i.e., mean changes from the pre- to posttest(s)]. Using
smoking cessation treatment as an example fromwhich we draw our illustrative dataset, researchers
have demonstrated that mean negative affect levels generally increase when smokers first quit, and
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that treatment with nicotine replacement therapy (NRT) results
in smaller changes in negative affect levels (Shiffman et al., 2006).
Standard statistical methods for testing mean differences include
uni- and multi-variate analysis of (co)variance ([M]AN[C]OVA)
and multigroup confirmatory factor analysis (MG-CFA,
Jöreskog, 1971). An advantage of MG-CFA over (M)AN(C)OVA
techniques is that the MG-CFA analysis uses latent variables
so that researchers can explicitly account for and quantify
the degree of measurement error and test for latent mean
differences (Bollen, 1989). Furthermore, the MG-CFA approach
is more flexible in terms of its assumptions (e.g., with regard
to whether homogeneity of variances across groups needs to be
assumed) and in terms of testing assumptions. For example, the
assumption of measurement equivalence (ME) across groups pre
and post treatment is implicitly made (but not formally tested)
within the (M)AN(C)OVA framework, whereas this assumption
can be tested within the MG-CFA framework via model fit
statistics.
In the present paper, we present extensions of current
multivariate latent variable techniques for group comparisons
in pre-post experimental (or quasi-experimental) designs when
researchers are interested in whether a treatment caused changes
not (or not only) in the latent means, but in the degree of
state variability. With state variability, we mean systematic intra-
individual fluctuations of people’s true scores across time. More
formally, within the framework of latent state-trait (LST) theory
described in detail below, state variability refers to deviations of
so-called latent state scores from so-called latent trait scores. For
example, it is well-known that people’s mood levels fluctuate to
a certain extent across time (e.g., Eid et al., 1999). Some people
may suffer not only from low average positive mood levels (e.g.,
due to a dysthymic personality), but also from large mood level
fluctuations (e.g., due to a bipolar disorder). As a consequence,
a treatment may be developed to (1) increase patients’ average
mood levels and (2) reduce the degree of intra-individual mood
fluctuations so that individuals’ mood levels become more stable
intra-individually after treatment.
Changes in state variability are frequently of interest to
researchers in addition to studying mean changes (Hedeker
et al., 2009). As another example, consider the following research
hypothesis pursued in the substantive-empirical portion of the
present article. Based on a randomized controlled trial (RCT),
Shiffman et al. (2006) were able to show that NRT can have
a significant positive effect on smoker’s mean affect levels after
quitting smoking as compared to a placebo group. In Shiffman
et al.’s (2006) study, smokers who received a nicotine patch
in the quitting phase on average reported significantly higher
positive affect and significantly lower negative affect compared
to a placebo group within the first 3 days of abstinence.
What has not been tested so far is whether NRT can also
have a positive effect in terms of decreasing intra-individual
affect variability, that is, on fluctuations in state affect around
individuals’ stable trait affect levels. In other words, in addition
to improving individuals’ overall trait (mean) affect, NRT might
be hypothesized to also have a “stabilizing effect” in terms of
reducing the extent to which individuals’ affect states fluctuate
across time after quitting. This might be expected because
nicotine withdrawal is thought to make (ex-)smokers more
emotionally volatile or irritable, that is, more reactive to affective
provocation (Acri and Grunberg, 1992).
Consider the following hypothetical example (illustrated in
Figure 1): Assume that an individual, say John, reports the same
general (i.e., average) true affect level of seven points on a
10-point Likert scale pre and post quitting. Although John has
the same general affect level of seven pre and post quitting, he
shows greater variability of his affect states around this general
level post quitting as compared to the pre-quitting phase. In the
example in Figure 1, John’s true scores fluctuate between 5 and 8
pre-quitting, whereas his true scores fluctuate more dramatically
between 2 and 10 post quitting. One could say that John’s affect
level has become more “state-like” (less stable) post-quitting.
In the present study, we demonstrate how extended latent
state-trait (LST) models can be used to test hypotheses with
regard to treatment-induced changes in state variability. To our
knowledge, our paper is the first to demonstrate the use of LST
models for this purpose.
Substantively, we tested the hypotheses that (1) smokers who
quit smoking would generally show increased intra-individual
state variability with regard to their affect post quitting as
compared to a pre-quitting phase and that (2) smokers in an NRT
group would show significantly less strongly increased intra-
individual mood variability levels after quitting compared to
smokers in a placebo group.
The purpose of the present paper is twofold. From
a methodological perspective, we show how multigroup-
multiphase latent state-trait (MG-MP-LST) models can be used
to test treatment effects in terms of differential changes between
groups in (1) latent trait means and (2) the amount of intra-
individual state variability. The MG-MP-LST models presented
here are extensions of multigroup LST models presented by
Steyer et al. (2015). From a substantive perspective, we test
whether NRT has a positive effect not only on smokers’ mean
positive mood (as was shown by Shiffman et al., 2006), but also
FIGURE 1 | Hypothetical example of a smoker who shows increased
intra-individual state variability of his affect true scores after quitting
smoking. The solid bar indicates the intra-individual true score mean, which
did not change from the pre- to the post-quitting phase.
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on smokers’ mood state variability (i.e., whether NRT leads to a
reduction in mood variability) after they quit smoking.
LST THEORY AND MODELS
LST theory and models have been developed to take systematic
intra-individual variability of human behavior into account in
the measurement of psychological attributes and to separate
stable (i.e., trait) from variable (situation-specific) components
of behavior and random measurement error (Steyer et al.,
1992)1. According to LST theory, intra-individual variability
in measurements across time can be due to (1) long-term
changes in the trait values, (2) short-term situation-specific
fluctuations (state variability), or (3) random measurement error
(Bishop et al., 2015). Models of LST theory allow researchers to
disentangle these three sources of variability and to quantify the
proportion of variability in an observed variable that is due to
1With “systematic intra-individual variability” we mean state variability that
cannot be explained by randommeasurement error, but is due to situational effects
or person× situation interactions in the sense of LST theory (Steyer et al., 1992).
(1) stable trait factors and/or trait changes, (2) fluctuating state
residual variability, and (3) random measurement error.
To illustrate the basic structure of LSTmodels, Figure 2 shows
a path diagram of an LST model with indicator-specific trait
factors (Eid, 1996). In this example, three observed variables
(indicators Yit , i = indicator, t = time point) were measured
on three time points. In the figure, Ti indicates a latent trait
factor pertaining to indicator i. Ti reflects the stable component
of behavior or emotion that does not vary across occasions of
measurement with regard to indicator i (e.g., habitual or “trait”
happiness). SRt indicates a latent state residual factor with amean
of zero that characterizes systematic residual variability at time
t (i.e., individuals’ true situation-specific deviations from their
stable trait values; e.g., deviations of state mood from trait mood).
The variances (Var) of the SRt factors thus capture the amount
of state variability in a given construct. When Var(SRt) = 0
for all t, there is no state variability, indicating that a construct
is perfectly trait-like. The variables eit indicate unsystematic
measurement error in the sense of classical test theory
(CTT; Novick, 1966) and thus have zero means by definition
as well.
FIGURE 2 | Path diagram of a multitrait-multistate (MTMS) model of LST theory for three indicators measured on three time points. The parameters φij
indicate covariances between indicator-specific trait factors.
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The model in Figure 2 is referred to as multitrait-multistate
(MTMS) model, because it uses as many trait factors Ti as there
are indicators. The rational for using as many trait factors as there
are indicators is that indicators in the social sciences frequently
contain systematic item- or indicator-specific variance that is
stable across time. In addition, indicators may measure slightly
different traits or distinct facets of the same trait. Because of
this heterogeneity, models with just a single trait factor typically
do not fit empirical data well (Geiser and Lockhart, 2012).
For example, the items happy and calm may both be viewed
as indicators of positive affect, yet they reflect (partly) distinct
dimensions or aspects of affect (e.g., calm implies a low-arousal
state, whereas happy does not). The measurement equation for
the MTMS model is given by:
Yit = Ti + δiSRt + eit, (1)
where latent means are estimated for all Ti factors (but no
intercepts αi). All factor loadings on the Ti factors are set to one
(i.e., λi = 1 for all i and t) and there is no constant intercept
parameter in the equation. (The rationale for this specification
is discussed in detail in Geiser et al., 2015).
In the model, all Ti’s are uncorrelated with all SRt and eit
variables, all SRt variables are uncorrelated with all eit , and all eit
variables are uncorrelated with each other. Correlations between
the indicator-specific trait factors Ti can be estimated. These
correlations indicate to which degree indicators are homogenous
(measure the same or closely related traits). High correlations
indicate homogeneity, moderate to low correlations indicate
heterogeneity of indicators. When Corr(Ti, Tj) = 1 for all i,
j, indicators are perfectly homogeneous so that a simpler LST
model with a single trait factor (so-called singletrait-multistate
or STMS model) can be used.
In the MTMS and other LST models, temporally adjacent
latent state residual variables SRt are frequently assumed to be
connected through a first-order autoregressive structure such
that
SRt = βtSRt−1 + ζt, (2)
where βt indicates a regression slope coefficient and ζ t indicates
a latent residual variable with a mean of zero that is uncorrelated
with all other latent and error variables in the model (Cole et al.,
2005).
Modeling an autoregressive structure as in Equation (2) can
be necessary when measurement occasions are closely adjacent
in time; in this case, there might be carry-over effects such that
the deviation from the trait score at time t depends in part
on the deviation at the previous time point t−1. For example,
mood deviations from a general mood level are typically stable
for at least a few hours. Such dependencies are less likely,
however, when time intervals between measurement occasions
are larger. In practice, researchers can empirically test whether
autoregressive effects are present by estimating both the MTMS
model with and without an autoregressive process and compare
the fit of the two models. If there is no difference in model fit
between the two model versions as indicated by a chi-square
difference test for nested models, then the researcher would
prefer the simpler model without autoregressive path coefficients.
Variance Components and Coefficients
The MTMS model allows for an additive decomposition of the
variance of the observed and latent true score variables (see
formulas in Table 1). According to the MTMS model, observed
variance Var(Yit) is the (weighted) sum of trait, state residual,
and error variance. True score variance Var(τit) is given as
the (weighted) sum of trait and state residual variance (i.e.,
excluding random error variance). Note that the larger the trait
variance relative to total true score variance, the more “trait-like”
a given construct; in contrast, the larger the state residual variance
relative to total true score variance, the more “state-like” a given
construct (and the larger the amount of state variability).
Based on the additive variance decomposition, coefficients can
be defined that formally represent these different proportions of
variability. The consistency coefficient CO gives the proportion
of variance that is accounted for by trait factors. CO thus
measures the degree of stability (“situation-independence”) of
a psychological construct. The occasion-specificity coefficient
OS gives the proportion of variance that is accounted for by
state residual factors. OS thus measures the degree of situation-
dependence (state variability) of a psychological construct.
The reliability coefficient Rel gives the proportion of observed
variance that is not due to random measurement error. Rel thus
has the same meaning as in CTT. The trait and state residual
variance components as well as the CO and OS coefficients are of
particular relevance to the present study. Below we explain how
an extended version of theMTMSmodel for multigroup pre-post
designs can be used to study treatment-related changes and group
differences in these variance components.
Extended LST Models for
Multigroup-Multiphase Designs
Traditionally, LST models such as the MTMS model shown in
Figure 2 have mostly been applied to single-group longitudinal
data without a treatment (e.g., pretest-posttest) component. For
example, Wu (2016) applied LST models to depression self-
report measures to determine the extent to which such measures
reflected a stable trait vs. fluctuating state construct. In the
present paper, we show how extended MG-MP-LST models
TABLE 1 | Variance decomposition and coefficients in the MTMS Model.
Variance/coefficient Equation
Observed variance Var(Yit ) = Var(τit ) + Var(eit )
True score variance Var(τit ) = Var(Ti ) + δi
2Var(SRt )
Consistency CO CO(τit ) = Var(Ti )/Var(τit )
Occasion-specificity OS OS(τit ) = δi
2Var(SRt )/Var(τit )
Reliability Rel Rel(Yit ) = Var(τit )/Var(Yit ) = [Var(Ti ) + δi
2Var(SRt )]/Var(Yit )
Yit, observed variable (i, indicator, t, time point). τit, true score variable. eit, measurement
error variable. Ti , indicator-specific trait factor. SRt, state residual factor. λi , trait factor
loading. δi , state residual factor loading.
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can be used to study changes in (1) trait values and (2) intra-
individual state variability based on a multigroup-multiphase
design when researchers have collected data on multiple time
points both pre and post treatment in two or more groups.
Steyer et al. (2015) presented MG-MP-LST models that can
be used in experimental and quasi-experimental pre-post designs
with multiple groups. Whereas Steyer et al. (2015) focused on
the use of MG-MP-LST models to examine treatment-induced
changes in trait means, in the present paper we demonstrate
the use of these models for studying changes in state and trait
variability.
A MG-MP-LST model with indicator-specific traits (MTMS
approach) is illustrated in Figure 3. There are two key differences
between the conventional MTMS model described above and
the MG-MP-LST model. First, the parameters of MG-MP-
LST models are estimated simultaneously in two or more
groups in line with multigroup CFA (Jöreskog, 1971). The
multigroup approach allows for group comparisons with regard
to (a) measurement-related parameters such as factor loadings,
intercepts, andmeasurement error variances to test forME across
groups (e.g., Widaman and Reise, 1997; Millsap, 2011) and (b)
structural parameters such as latent factor means, variances, and
covariances. Second, as discussed in more detail below, MG-MP-
LST models estimate separate (but correlated) trait factors for
different phases, for example, (1) a pre- vs. (2) a post-treatment
phase.
Figure 3 illustrates an MG-MP-LST model for a design
with three indicators, three measurement occasions in the
pre- and post-treatment phase, respectively, and two groups
(i.e., a placebo = control group and an NRT = treatment
group). Note that extensions of the model to more indicators,
time points, or groups are straightforward. It can be seen
that in the MG-MP-LST model there are separate indicator-
specific trait factors for (1) the pre- and (2) the post-treatment
phase. Therefore, individuals’ trait scores in the pre-treatment
phase need not be the same as the trait scores in the post-
treatment phase. This reflects the assumption that a treatment
might cause (more enduring) changes to individuals’ latent trait
FIGURE 3 | Path diagram of a multigroup-multiphase-(MG-MP-)LST model for three indicators measured on three time points pre- and post an
intervention (here: quitting smoking) in two groups (here: placebo vs. NRT). All indicator-specific trait factors can be correlated within and across phases.
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scores, potentially resulting in changes in the trait means or
variances.
For example, quitting smoking without NRT might cause
a decrease in the trait factor mean for the item happy post-
quitting in the placebo group, indicating an overall decrease in
positive trait mood in this group, due to nicotine withdrawal, or
removal of positive-affect-enhancing effects of nicotine use. In
addition, quitting without NRT may cause a decrease in the trait
factor variance for the same item (relative to the total true score
variance), indicating an overall decrease in the intra-individual
stability of this trait (i.e., the construct may have become less
trait-like as a result of quitting as mood becomes more volatile).
Furthermore, the model contains separate latent state residual
factors for each measurement occasion within the pre- and post-
treatment phase. Note that similar to the trait factor variances,
the variances of the state residual factors can vary across the pre-
and post-treatment phases. A change in the amount of latent
state residual factor variance from pretest to posttest (relative to
total true score variance) would indicate changes in the amount
of intra-individual state variability. For example, the amount
of state residual factor variance for mood items may increase
relative to the total true score variance from the pre- to post-
quitting phase. This would indicate that a construct has become
less stable (i.e., less trait-like and more state-like) as a result of
quitting and/or NRT. Given that the latent state residual factors
are defined as regression residual factors in LST theory (Steyer
et al., 1992, 2015), these factors have zero means by definition
in each group. Mean changes from the pre- to the post-quitting
phase can (and need) only be assessed for the trait factors in the
model.
The model in Figure 3 uses indicator-specific trait factors.
Therefore, this model allows for the possibility that each item
could show differential changes with regard to the trait means or
with regard to the amount of trait and state variability across the
pre- and post-quitting phases. For example, the responses to the
item happy may be more or less affected by quitting and/or NRT
than responses to the items calm or content. This is an advantage
of the model compared to models with a single general trait
factor, which implicitly assume that all indicators are similarly
affected by potential treatment effects.
PARAMETER INVARIANCE TESTING
ACROSS GROUPS AND TIME
A general advantage of the multigroup CFA modeling approach
over (M)AN(C)OVA methods is the flexibility with which the
multigroup CFA approach allows testing various measurement
and structural (latent variable) parameters of interest for
invariance across groups. In this way, numerous hypotheses
with regard to pre/post and group differences can be tested via
model (goodness-of-fit) comparisons. The most parsimonious
model (i.e., the model that shows the highest level of parameter
invariance across groups —i.e., “group equality”) that still shows
an appropriate fit is typically selected. The model comparisons
allow researchers to make statements about the extent to
which (1) the groups differ with regard to measurement and/or
structural parameters before and after the treatment, (2) whether
there are changes in measurement and/or structural parameters
from the pre- to post-treatment phase within each group, and (3)
whether treatment groups showed stronger changes in relevant
parameters from the pre- to post-treatment phase compared to
control groups.
For meaningful comparisons of latent variable variances
across groups and time, factor loadings should be equivalent
across groups and time (Widaman and Reise, 1997). In the case
of the MG-MP-LST model, this means that for a meaningful
comparison of state residual factor variances across groups and
time, the state residual factor loadings should be invariant across
groups g and phases (i.e., δPREig = δ
PRE
ig′ = δ
POST
ig = δ
POST
ig′
for all i, g). For meaningful comparisons of latent variable
means, both factor loadings and intercept parameters should
be equivalent across groups and time. Note that in the MTMS
model all intercept parameters are implicitly zero and all trait
factor loadings are equal to 1 by definition (Geiser et al., 2015).
Therefore, invariance of the intercepts and trait factor loadings
across groups and time is implied in the MTMS model. In
addition to the state residual factor loadings, researchers can test
whether measurement error variances are equivalent across time
and groups.
MATERIALS AND METHODS
Sample
We re-analyzed data from N = 338 smokers who participated in
a randomized controlled trial, in which smokers were randomly
assigned to a placebo group (n= 147) or anNRT group (n= 191).
In the quitting phase, participants in the NRT group received
nicotine patches, whereas placebo group members received
placebo patches.More details on the sample, recruitment process,
and procedure are described in Shiffman et al. (2006).
Measures and Procedure
Smokers provided self-reports of their affect via ecological
momentary assessments (EMA) for a period of about 2 weeks
prior to quitting (pre-quitting phase) as well as for a period of
about 6 weeks after quitting (post-quitting phase). For the present
methodological illustration, we selected three items measuring
positive affect (happy, content, calm; Cronbach alpha = 0.8) that
were assessed on a scale from 0 (minimal positive affect) −10
(maximal positive affect). Given the large number of response
categories, we treated the items as continuous variables in the
analyses.
For the present application and illustration of MG-MP-
LST models and to simplify the analysis, we selected three
measurement occasions in the pre-quitting phase and three
measurement occasions in the post-quitting phase from each
participant’s responses to the three affect items. The pre-quitting
data recording period lasted for 16 days. On Day 9, participants
practiced quitting (“trial abstinence period”; Shiffman et al.,
2006). We therefore selected data from the first 8 days within
the pre-quitting phase. This allowed us to avoid the potential
effects that trial abstinence might have on smoker’s affect as well
as a potential affect disturbance during the days directly before
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the actual quitting phase due to an anticipation of withdrawal
symptoms. In order to allow participants to acclimate to the
EMA devices we excluded all data recorded on the first day of
measurement in the pre-quitting phase. The approximate time
interval between the measurement occasions included in the
present analysis was ∼2–3 days for both the pre- and post-
quitting phase.
We also excluded data from the first day of abstinence (the first
day of the post-quitting phase) in order to avoid bias due to the
initial affect disturbance immediately after quitting, and to allow
time for the effects of NRT to become evident. All measurements
taken from reports of smoking during the pre- or post-quitting
phase were excluded from the analysis. That is, we used only
randomly prompted non-smoking occasions pre-quitting and
excluded data from participants after a relapse post quitting (for
participants who experienced a relapse at some point within the
post-quitting phase, we still included all pre-quitting data as well
as all post-quitting data prior to the relapse in the analysis). The
Mplus script for specifying the final model can be found in the
online Supplementary Materials.
RESULTS
In order to examine potential effects of NRT on smoker’s mood
variability, we used MG-MP-LST analysis (Steyer et al., 1992,
2015) as described above. In the first step of our analysis, we
estimated separate models within each group and phase. This
was done for several reasons. First, this allowed us to test
whether a model with indicator-specific traits (MTMS approach)
was needed or whether a simpler model with a general trait
factor (STMS approach) could be used. Second, it allowed us
to check whether the inclusion of an autoregressive structure
(Equation 2) was necessary. Third, estimating separate models
within each group and phase allowed us to test for ME within and
across phases within each group. In summary, these preliminary
analyses allowed us to make informed decision as to which
model should be used for the combined multigroup-multiphase
analysis.
Our preliminary analyses revealed statistically significant
indicator-specificity (i.e., the trait components of the items happy,
calm, and content did not follow a unidimensional structure).
This was shown by the fact that models with a single trait
factor (STMS approach) fit significantly worse than models with
indicator-specific traits (MTMS approach) in both groups and
phases. We therefore used the MTMS approach in all subsequent
analyses. Furthermore, our preliminary analyses revealed that the
inclusion of autoregressive effects was not necessary as indicated
by non-significant chi-square difference tests for comparisons
of model versions with and without autoregressive effects as
well as non-significant βt coefficients. We therefore used an
MTMS approach without autoregressive structure in our final
combined MG-MP-LST model. Finally, the preliminary analyses
revealed that invariant latent state residual factor loadings (δ)
could be assumed within phases within each group, so that we
used models with time-invariant δ-parameters within phases in
the combined MG-MP-LST analysis. Error variances were found
to be non-invariant across time, so that we left the error variances
unconstrained in subsequent analyses.
Table 2 shows model goodness-of-fit tests and descriptive
indices for all versions of the combined MG-MP-LST model that
we tested. RMSEA values < 0.05 as well as CFI values > 0.95
are commonly seen as indicative of an appropriate model fit
(Hu and Bentler, 1999). Model comparisons were based on chi-
square difference tests (with non-significant chi-square difference
values indicating that a more restricted model did not fit worse
than the more general model that it was compared to) and AIC
values (with smaller AIC values indicating better fit). Model 1
represented the least restrictive version of the model in Figure 3.
In Model 1, all free parameters (i.e., parameters that are not fixed
TABLE 2 | Model goodness-of-fit measures for different MG-MP-LST models with indicator-specific trait factors fit to smoker’s affect data.
Model χ2 df p RMSEA CFI AIC χ21 df1 p(χ21)
1. δi loadings free across groups 381.37 268 <0.001 0.05 0.95 20049
2. δi loadings equal across groups 394.49 274 <0.001 0.05 0.94 20051 13.12 6 0.004
3. δi loadings equal across groups except for content 383.61 273 <0.001 0.05 0.95 20042 2.24 5 0.82
4. Equal SRt variances within each group and phase 395.46 281 <0.001 0.05 0.94 20037 11.85 8 0.16
5. Equal SRt variances across groups within each phase 400.77 283 <0.001 0.05 0.94 20039 5.31 2 0.07
6. All SRt variances equal 406.25 284 <0.001 0.05 0.94 20042 5.48 1 0.02
7. Equal Ti variances across groups within each phase 405.84 289 <0.001 0.05 0.94 20032 5.07 6 0.53
8. Equal Ti variances across groups and phases 419.03 292 <0.001 0.05 0.94 20039 13.20 3 0.004
9. Equal Ti variances across phases only for happy 408.01 290 <0.001 0.05 0.94 20032 2.18 1 0.14
10. Equal Ti variances across phases for happy and calm 415.85 291 <0.001 0.05 0.94 20038 7.84 1 0.01
11. Equal Ti variances across phases for happy and content 414.13 291 <0.001 0.05 0.94 20036 6.11 1 0.01
12. Equal Ti means across groups within each phase 423.60 296 <0.001 0.05 0.94 20036 15.59 6 0.02
13. Equal Ti means across groups only pre-quitting 413.53 293 <0.001 0.05 0.94 20032 5.52 3 0.14
14. Equal Ti means across phases only in placebo group 417.43 296 <0.001 0.05 0.94 20029 3.90 3 0.27
15. Equal Ti covariances across groups within each phase 427.93 302 <0.001 0.05 0.94 20028 10.49 6 0.11
RMSEA, root mean square error of approximation; CFI, comparative fit index; AIC, Akaike’s information criterion. Bold face indicates lowest AIC value.
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by definition of the model) were allowed to vary between the
placebo and NRT groups. Specifically, Model 1 allowed the state
residual factor loadings, measurement error variances, trait factor
variances, trait factor means, and trait factor covariances as well
as the state residual factor variances to differ between groups.
Model 1 thus served as an unrestrictive baseline model. This
model showed a reasonably good fit to the data as indicated by
the RMSEA and CFI so that we used this model for subsequent
invariance tests across groups.
In Model 2, we constrained all latent state residual factor
loadings (δ) to be equal across groups. The chi-square difference
test for the comparison between Model 2 and Model 1 was
significant, indicating that the assumption of equal factor
loadings for all items was too restrictive. A closer investigation of
the individual loadings revealed that the unstandardized loadings
for the item content had dropped significantly in the placebo
group from the pre- to the post-quitting phase [from 1.36
(SE = 0.14) to 0.39 (SE = 0.17)] This may indicate that the
situation-specific effects were to a lesser extent shared between
this item and the two other items in the placebo group post-
quitting. We discuss potential substantive explanations for this
phenomenon in the Discussion section.
A model version with partial invariance of the loadings
(loadings for content left free to vary post quitting in the
placebo group only; Model 3) did not fit significantly worse
than Model 1 according to the chi-square difference test. Given
that the ME assumption was not rejected for the loadings of
the two remaining items, we used Model 3 with partial ME
in subsequent analyses (partial state residual factor loading
invariance is sufficient for meaningful comparisons of state
residual factor variances across groups)2. With Model 4, we
examined whether the state residual factor variances could be
assumed to be equal within each group and phase, respectively.
This model did not impose any across-group or across-phase
invariance constraints on the state residual factor variances.
Model 4 was useful to test, because if the state residual factor
variances could be set equal within each group and phase, this
would facilitate the comparison of state residual factor variances
across groups and phases and save additional parameters, making
the overall model more parsimonious. The chi-square difference
test for the comparison between Model 4 and Model 3 was non-
significant, indicating that the assumption of equal state residual
factor variances within each group and phase was not rejected.
In the next step (Model 5), we tested whether the state residual
factor variances were equal across groups within each phase
(without constraining these variances to be equal across the
pre- and post-quitting phases). Model 5 did not fit significantly
worse than Model 4 indicating that the state residual factor
variances could be assumed to be equal across groups within the
pre- and post-quitting phases, respectively. Using Model 6, we
tested whether all state residual factor variances were equal (i.e.,
whether these variances were not only equal between groups, but
2We also conducted invariance tests for the error variances Var(eit). Invariance
of the error variances across groups and phases could not be established for the
present data. Given that invariance of the error variances is not critical for the
latent variable parameter comparisons described in this paper we do not report
these analyses in detail here.
also between phases). Model 6 fit significantly worse than Model
5, indicating that the assumption of equal state residual factor
variances across the pre- and post-quitting phase was rejected.
Inspection of the estimated state residual factor variances in
Model 5 revealed that, contrary to our substantive hypothesis,
these variances were larger in the pre-quitting as compared to
the post-quitting phase, indicating a decrease in state variability
from pre- to post-quitting in both groups. We therefore used
Model 5 for further invariance tests. Model 7 tested whether the
trait factor variances were equal across groups within each phase.
This assumption was not rejected by the chi-square difference
test, as Model 7 did not fit significantly worse than Model 5.
In the next step (Model 8), we tested whether the trait factor
variances were equal across phases. The chi-square difference test
for the comparison betweenModel 8 andModel 7 was significant,
indicating a significant difference in at least some of the trait
variances across phases. A closer investigation revealed that the
trait variances differed across phases for the items calm and
content, whereas they could be assumed to be equal for the item
happy (see Table 2, Models 9 through 11).
Model 12 tested whether trait factor means were equal across
groups within each phase. This assumption was rejected by
the chi-square difference test. In contrast, Model 13, in which
the trait factor means were assumed to be equal across groups
only in the pre-quitting phase (but not post quitting) did not
fit significantly worse than Model 9. In Model 14, we tested
whether the trait factor means were equal across phases in the
placebo group only. Model 14 did not fit significantly worse than
Model 13, indicating that the trait factor means did not change
significantly from the pre- to post quitting phase in the placebo
group, whereas the post-quitting trait means were significantly
larger in the NRT group as compared to the pre-quitting means
in this group.
Model 15 tested whether the trait factor covariances could
be assumed to be equal across the placebo and NRT groups
within the pre- and post-quitting phase. This assumption was not
rejected as indicated by a comparison of the chi-square values
between Model 15 and 14. We therefore selected Model 15 as our
final model.
In summary, the invariance analyses revealed that in both
the placebo and NRT groups, the state residual factor variances
decreased significantly from the pre- to the post-quitting phase,
indicating a significant reduction in intra-individual affect state
variability after quitting smoking in both groups. At the same
time, the trait factor variances for the items calm and content
increased significantly in both groups from the pre- to post
quitting phase, showing that individuals’ responses became more
stable after quitting. Although, there was a significant mean
difference in trait positive affect between groups post quitting
(with higher means in the NRT group), the state residual and
trait factor variances did not differ between groups (neither pre-
nor post quitting). This indicated that NRT did not differentially
influence affect variability as compared to placebo treatment.
Table 3 shows the estimated parameters for Model 15. The
CO, OS, and Rel coefficients that were calculated based on
the same model can be found in Table 4. Given that the state
residual factor variances were set equal within each phase, the
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TABLE 3 | Parameter estimates for Model 15.
Parameter Placebo group NRT group
Estimate SE Standardized estimate
[range]
Estimate SE Standardized estimate
[range]
PRE-QUITTING PHASE
State residual loading happy δPRE1 1
a
−
a [0.46; 0.48] 1a −a [0.45; 0.46]
State residual loading calm δPRE2 1.13
b,c,e 0.11b,c,e [0.51; 0.52] 1.13b,c,e 0.11b,c,e [0.47; 0.48]
State residual loading content δPRE3 1.28
b,e 0.12b,e [0.54; 0.59] 1.28b,c,e 0.12b,c,e [0.50; 0.58]
Trait loading happy λPRE1 1
a
−
a [0.66; 0.68] 1a −a [0.64; 0.66]
Trait loading calm λPRE2 1
a
−
a [0.58; 0.59] 1a −a [0.54; 0.55]
Trait loading content λPRE3 1
a
−
a [0.57; 0.63] 1a −a [0.53; 0.62]
Error variance happy Var(εPRE1t ) [range] [1.31; 1.69] [0.28; 0.30] [1.63; 2.00] [0.27; 0.32]
Error variance calm Var(εPRE2t ) [range] [1.81; 2.05] [0.34; 0.37] [2.61; 2.79] [0.30; 0.41]
Error variance content Var(εPRE3t ) [range] [1.17; 2.19] [0.30; 0.41] [1.30; 3.02] [0.31; 0.47]
State residual variances Var(SRPRE ) 1.00b,e 0.14b,e 1.00b,e 0.14b,e
Trait variance happy Var(TPRE1 ) 2.02
c,e 0.19c,e 2.02c,e 0.19c,e
Trait variance calm Var(TPRE2 ) 1.68
e 0.24e 1.68e 0.24e
Trait variance content Var(TPRE3 ) 1.83
e 0.25e 1.83e 0.25e
Trait mean happy E(TPRE1 ) 7.52
c,e 0.09c,e 7.52c,e 0.09c,e
Trait mean calm E(TPRE2 ) 7.39
c,e 0.09c,e 7.39c,e 0.09c,e
Trait mean content E(TPRE3 ) 7.01
c,e 0.09c,e 7.01c,e 0.09c,e
Trait covariance happy, calm Cov(TPRE1 , T
PRE
2 ) 1.21
e 0.18e 0.66e 1.21e 0.18e 0.66e
Trait covariance happy, content Cov(TPRE1 , T
PRE
3 ) 1.41
e 0.18e 0.73e 1.41e 0.18e 0.73e
Trait covariance calm, content Cov(TPRE2 , T
PRE
3 ) 1.38
e 0.20e 0.79e 1.38e 0.20e 0.79e
POST-QUITTING PHASE
State residual loading happy δPOST1 1
a
−
a [0.36; 0.43] 1a −a [0.41; 0.42]
State residual loading calm δPOST2 1.13
c,d,e 0.11c,d,e [0.40; 0.47] 1.13c,d,e 0.11c,d,e [0.40; 0.41]
State residual loading content δPOST3 0.66
d 0.20d [0.24; 0.26] 1.28c,d 0.12 c,d [0.46; 0.49]
Trait loading happy λPOST1 1
a
−
a [0.61; 0.73] 1a −a [0.70; 0.70]
Trait loading calm λPOST2 1
a
−
a [0.69; 0.80] 1a −a [0.68; 0.71]
Trait loading content λPOST3 1
a
−
a [0.71; 0.76] 1a −a [0.69; 0.75]
Error variance happy Var(εPOST1t ) [range] [1.12; 2.69] [0.35; 0.57] [1.37; 1.46] [0.25; 0.28]
Error variance calm Var(εPOST2t ) [range] [0.62; 1.97] [0.35; 0.51] [2.03; 2.18] [0.37; 0.39]
Error variance content Var(εPOST3t ) [range] [1.65; 2.39] [0.39; 0.56] [0.94; 1.72] [0.26; 0.35]
State residual variances Var(SRPOST ) 0.71d,e 0.12d,e 0.71d,e 0.12d,e
Trait variance happy Var(TPOST1 ) 2.02
c,e 0.19 c,e 2.02 c,e 0.19 c,e
Trait variance calm Var(TPOST2 ) 2.66
e 0.32e 2.66e 0.32e
Trait variance content Var(TPOST3 ) 2.66
e 0.31e 2.66e 0.31e
Trait mean happy E(TPOST1 ) 7.52
c 0.09c 7.81 0.13
Trait mean calm E(TPOST2 ) 7.39
c 0.09c 7.73 0.15
Trait mean content E(TPOST3 ) 7.01
c 0.09c 7.33 0.15
Trait covariance happy, calm Cov(TPOST1 , T
POST
2 ) 1.69
e 0.21e 0.73e 1.69 e 0.21e 0.7e
Trait covariance happy, content Cov(TPOST1 , T
POST
3 ) 1.92
e 0.20e 0.83e 1.92e 0.20e 0.83e
Trait covariance calm, content Cov(TPOST2 , T
POST
3 ) 2.03
e 0.26 0.76e 2.03e 0.26 0.76e
ACROSS PHASES
Trait covariance happy pre-post Cov(TPRE1 , T
POST
1 ) 1.47 0.24 0.73 1.38 0.22 0.68
Trait covariance calm pre-post Cov(TPRE2 , T
POST
2 ) 0.90 0.30 0.43 1.38 0.25 0.65
Trait covariance content pre-post Cov(TPRE3 , T
POST
3 ) 1.46 0.31 0.66 1.33 0.24 0.60
afixed parameter.
bParameter set equal across time within the pre-quitting phase.
cParameter set equal across the pre- and post-quitting phases.
dParameter set equal across time within the post-quitting phase.
eParameter set equal across placebo and NRT groups.
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TABLE 4 | Estimates of consistency, occasion-specificity, and reliability
derived from Model 15.
Item Placebo group NRT group
CO(τi ) OS(τi ) Rel(Yi ) [range] CO(τi ) OS(τi ) Rel(Yi ) [range]
PRE-QUITTING PHASE
Happy 0.67 0.33 [0.64; 0.70] 0.67 0.33 [0.60; 0.65]
Calm 0.57 0.43 [0.59; 0.62] 0.57 0.43 [0.51; 0.53]
Content 0.53 0.47 [0.61; 0.75] 0.53 0.47 [0.53; 0.73]
POST-QUITTING PHASE
Happy 0.74 0.26 [0.50; 0.71] 0.74 0.26 [0.65; 0.67]
Calm 0.75 0.25 [0.64; 0.85] 0.75 0.25 [0.62; 0.67]
Content 0.90 0.10 [0.55; 0.64] 0.70 0.30 [0.69; 0.80]
CO(τi ), consistency coefficient; OS(τi ), occasion-specificity coefficient; Rel(Yi ), reliability
coefficient. For each item, CO(τi ) and OS(τi ) add up to 1 (100% true score variance).
The CO(τi ) and OS(τi ) coefficients are equal across groups due to the tested invariance
constraints, except for the item content due to the non-invariant loadings of this item post
quitting.
items showed the same CO and OS values within each phase
and are thus given only once. Further note that since the trait
and state residual factor variances were set equal across groups
within the pre-quitting phase, all CO and OS values are identical
across groups pre-quitting (as one would expect in a randomized
controlled trial before the treatment phase). Post-quitting, the
CO and OS values are also identical, except for the item content,
which showed non-invariant loadings from the pre- to post-
quitting phase in the placebo group. Because of the drop in
the factor loadings, this item has a much higher CO value post
quitting as compared to the pre-quitting CO value. We discuss
this issue more in the Discussion Section.
As can be seen from the CO and OS coefficients in Table 4,
the item happy showed the highest level of stability (trait-like
aspects) of the three items in the pre-quitting phase, with about
67% of this item’s true score variability being attributable to trait
influences and only about 33% of the true score variability being
due to situation-specific fluctuations (deviations of individuals’
true states from their true trait levels). Post quitting, the item
happy showed slightly increased stability, with now 74% of its true
score variance representing trait variance. Note, however, that
the corresponding trait variance component was not statistically
significantly larger post-quitting for this item in either group.
This result is therefore purely descriptive.
In contrast, both the items calm and content showed
statistically significantly larger trait variance components post
quitting in both groups. For calm, the percentage of trait
variability increased from 57% in the pre-quitting phase to 75% in
both groups. The item content showed an increase from 53% trait
variance pre-quitting to 90% trait variance in the placebo group
and 70% in the NRT group.
DISCUSSION
In the present article, we illustrated howMG-MP-LSTmodels can
be used to study changes in the amount of intra-individual state
variability in studies that include a pre- and post-intervention
phase. To our knowledge, the present paper is the first to discuss
the use of such models to study potential experimental effects on
state and trait variability. We presented an empirical application
of these models to smokers’ affect levels before and after an NRT
intervention (vs. placebo). By using models that are derived from
LST theory, researchers are able to clearly distinguish between
changes in trait mean levels and changes in state variability.
Furthermore, researchers can separate out variability that is
due to random measurement error. The multigroup modeling
approach has the advantage that a number of assumptions (such
as ME across time and groups) can be formally tested through
nested model comparisons. This approach also makes it easy to
compare groups with regard to their latent trait means and the
amount of latent trait and state residual variability. It should be
noted that the present MP-LST approach can also be used in
single-group designs (e.g., when there is no control group), for
example, to study whether smokers’ affect variability varies across
certain situations (e.g., in smoking vs. non-smoking situations).
Previous research has shown that NRT can help improvemean
levels of positive affect after quitting relative to placebo (Shiffman
et al., 2006). In the present study, we had specific hypotheses
about the effects of quitting smoking and the NRT intervention
on individuals’ affect variability. We expected that smokers’
affect levels would become more volatile after quitting, leading
to increased state variability in the post-quitting as compared
to the pre-quitting phase. Furthermore, we expected the NRT
intervention to decrease the amount of intra-individual affect
variability relative to placebo treatment after quitting. MG-MP-
LST models are perfectly suited for testing hypotheses of this
kind, because they allow researchers to distinguish between trait,
state residual, and measurement error sources of variability, to
considermultiple groups simultaneously (here: NRT vs. placebo),
and to compare different phases (here: pre vs. post quitting)
within and across groups.
Contrary to our hypotheses, we found that the amount
of state variability in smokers’ self-reported affect states was
significantly decreased in both the NRT and the placebo group
after quitting. Furthermore, we found that the items calm and
content (but not the item happy) showed significantly increased
trait variances after quitting in both groups. This indicated that
smokers’ affect states tended to be more consistent and less
variable (intra-individually) after they quit smoking. Although
the groups differed significantly in their affect trait means post
quitting (with higher trait means in the NRT group), we did
not find a significant difference between the groups with regard
to trait and state residual variances post quitting. Whereas
it was expected that withdrawing from smoking would make
mood more volatile, the data showed that mood actually became
more stable, perhaps reflecting smokers anhedonic state during
initial abstinence. Epping-Jordan et al. (1998) have demonstrated
that nicotine withdrawal can raise the reinforcement threshold,
making activities less reinforcing and perhaps thus limiting the
ability of activities and contexts to raise mood, resulting in less
variability.
An alternative hypothesis to explain the reduced variability
in self-rated mood after quitting is that participants engaging in
the many assessments required by EMA may develop stereotypic
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response styles after repeated assessments. Such a response bias
could have led to seemingly more “consistent” responses in
the second half of the data collection. To test this alternative
hypothesis, we applied single-group MP-LST models to another
EMAdataset in which smokers were not trying to quit, but simply
completed assessments over 3 weeks, with no intervention or
change in smoking status (for details on this non-quitting data
set, see Shiffman et al., 2014). In these data, we did not find
a significant reduction in smokers’ affect state variability when
examining a similar time frame as in the main study, although
the items happy and calm showed significant increases in trait
variance (26 and 27%, respectively) across time (the item content
was not assessed in that study), leading to higher consistency and
lower occasion-specificity values in the second half of the study.
In the quitting data example reported in the present paper,
we observed a significant and large (29%) reduction in state
variability from the pre- to the post-quitting phase in both
the NRT and placebo groups. Moreover, in the quitting study,
the increases in trait variance for calm (58%) and content
(45%), but not happy, were substantially larger than in the data
set without quitting. Taken together, these results suggest that
quitting smoking itself may indeed have an effect to reduce state
variability in positive mood above and beyond potential response
style effects. This could be due to repeated smoking, which leads
to large fluctuations in nicotine levels as nicotine concentrations
spike immediately after smoking and then decline with nicotine
clearance. However, additional studies are needed to confirm
this effect. In addition, alternative explanations for the observed
effects that we cannot fully rule out may include maturation and
testing effects.
Relations to Other Methods
The MG-MP-LST models presented and applied in the present
paper are closely related (but not identical) to models discussed
by Eid and Hoffmann (1998) as well as Steyer et al. (2015).
Whereas Eid and Hoffmann (1998) as well as Steyer et al. (2015)
focused on the use of LST models in the assessment of mean
changes and/or causal effects, the present paper focuses on the
use of such models for examining changes in intra-individual
state variability from pre- to posttest in an experimental setting.
Hedeker et al. (2012; see also Hedeker et al., 2009) recently
presented a multilevel modeling approach to studying intra-
individual variability in EMA data. One difference between
Hedeker et al.’s approach and the LST approach presented here
is that the LST approach uses multiple indicators and latent
variable variance components that are corrected for random
measurement error, whereas Hedeker et al.’s approach uses single
indicators and assesses variability in the error variables. Hence,
Hedeker et al.’s approach does not separate true state variability
from random error variability. In contrast, the LST approach
uses multiple indicators and therefore enables researchers to
explicitly distinguish between trait latent variables (reflecting
true person effects), state residual latent variables (reflecting
true situation and/or person-situation interaction effects), and
measurement error variables (reflecting random measurement
error). The LST approach thus allows separating true state
variability from random measurement error. An advantage
of the LST approach is therefore that it clearly separates
systematic variability in individuals’ responses from unreliable
error variability. Moreover, the LST approach allows considering
multiple items or scales simultaneously, whether these indicators
measure a single unidimensional trait (STMS approach) or
multiple distinct facets of one or several traits (MTMS approach
as illustrated here). This allows researchers to study and compare
multiple related items or other indicators simultaneously and
to assess ME across groups and phases. The LST approach
also allows researchers to relate both trait and state residual
components to external variables (e.g., grouping variables as in
the present paper).
Furthermore, the LST approach allows researchers to include
systematic autoregressive effects among latent state residual
variables if necessary (Cole et al., 2005). Such short-term stability
effects must be expected in intensive longitudinal studies that use
very small intervals betweenmeasurement occasions (such as just
a few hours). In the present study, we tested for autoregressive
effects, but found those to be non-significant so that we could use
simpler models without these effects.
The LST approach also allows researchers to test for ME
within and across phases as well as between groups. This is
another advantage compared to (M)AN(C)OVA and other more
conventional statistical approaches that implicitly make the
assumption of ME, but do not allow testing it. In our application,
the item content showed decreased state residual factor loadings
in the placebo group in the post-quitting phase as compared
to the pre-quitting phase in the same group. This may indicate
that the state residual components (i.e., the occasion-specific
deviations of the state from the trait scores) for the item content
were to a lesser extent shared with the two other items (happy
and calm) post quitting in this group. One might speculate
that the experience of contentment relates more strongly to the
experience of reinforcement and is thus more affected when
nicotine withdrawal is more intense.
In the present case, a sufficient level of partialME between pre-
and post-quitting phase could still be established (Byrne et al.,
1989) so that we were able to make meaningful comparisons of
state residual factor variances, trait variances, and trait means
across groups and phases. Recent techniques for establishing
approximate ME (van de Schoot et al., 2013) may also be useful
in cases in which full ME cannot be established.
Limitations
The models discussed here require a relatively large amount
of data. Specifically, researchers need to collect data from at
least two items or scales on at least two measurement occasions
in at least two groups (1) pre and (2) post treatment. This is
the minimal design for estimating the described models. We
would generally recommend using more indicators and time
points within each phase if possible in order to prevent potential
model identification and estimation problems and to obtain
more dependable parameter estimates. In addition, although it
is generally difficult in structural equation modeling to make
general sample size recommendations, the required sample size
for complex latent variable models such as the MG-MP-LST
models is clearly larger than for observed variable methods such
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as (M)AN(C)OVA. The large amount of required data (especially
with regard to the overall sample size) can place a burden on
the investigator and may not always be realistic to achieve. An
alternative to the described models for smaller sample sizes could
be Hedeker et al.’s (2012) multilevel approach, which does not
rely on latent variables and may thus be more appropriate for
smaller samples than the LST approach.
The approach with indicator-specific trait factors presented
here is flexible in that it allows researchers to use and study
a set of potentially heterogeneous indicators. Each indicator
can be studied separately in terms of both mean changes and
changes in state variability. One drawback of this flexibility is
that researchers may sometimes find it difficult to come up with
specific hypotheses for each indicator. Instead, they may wish
to study only a single “general” trait factor. When researchers
are interested in studying a single general trait factor, other
versions of the basic LST model can be adapted for an MG-
MP-LST design. For example, Eid et al. (1999) as well as Geiser
and Lockhart (2012) described an LST model with a general
trait factor and I – 1 specific (residual method) factors to
model indicator-specificity (where I indicates the total number
of indicators to be modeled). Eid et al.’s (1999) model is an
alternative to the indicator-specific approach presented here
when researchers want to study general trait factors. Their
approach can be easily adapted to an MG-MP-LST design.
CONCLUSIONS
MG-MP-LST models are comprehensive longitudinal models
that allow experimental and quasi-experimental researchers
to test a wide variety of hypotheses with regard to group
differences and treatment effects. Many researchers who use
(quasi)experimental designs may find MG-MP-LST models
to be particularly useful in cases in which interventions,
experimental manipulations, or other treatments are
hypothesized to affect individuals’ intra-individual variability
levels—for example, when treatments are expected to have a
“stabilizing” effect in terms of reducing intra-individual state
variability.
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